


Chemicals & Petrochemicals | Small Cap
Saroja Pharma Industries India Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation. Efficiency ratios are also notable, driven by high turnover in fixed assets and inventory. However, liquidity is a concern, with low cash and operating cash flow ratios. Growth metrics present a varied picture, with strong revenue and asset growth offset by a decline in earnings per share. The company's coverage ratios are also weak, reflecting limited ability to cover interest and dividends. These factors suggest that while the company is profitable and growing, it needs to strengthen its short-term financial health and improve earnings efficiency. Future success depends on balancing growth initiatives with sustainable financial practices.
Saroja Pharma Industries India Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation. Efficiency ratios are also notable, driven by high turnover in fixed assets and inventory. However, liquidity is a concern, with low cash and operating cash flow ratios. Growth metrics present a varied picture, with strong revenue and asset growth offset by a decline in earnings per share. The company's coverage ratios are also weak, reflecting limited ability to cover interest and dividends. These factors suggest that while the company is profitable and growing, it needs to strengthen its short-term financial health and improve earnings efficiency. Future success depends on balancing growth initiatives with sustainable financial practices.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
11.08
Industry Median
22.59
Small Cap Median
21.70
P/E RATIO
13.67
P/B RATIO
0.87
Industry Median
1.76
Small Cap Median
1.77
P/S RATIO
0.26
Industry Median
0.89
Small Cap Median
0.88
Others
PEG RATIO
0.00
EV/EBITDA RATIO
4.71
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹35 as on Jun 15, 2026.
The company demonstrates strong growth in revenue and assets, but earnings per share growth is a concern. High growth rates in revenue and assets indicate successful expansion, while negative EPS growth suggests challenges in translating revenue into profits. This mixed performance requires attention to improve profitability alongside growth.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 51.75 | -9.78 | -18.97 | 32.11 | 30.73 |
| Operating Profit Growth Rate | 61.54 | 29.52 | -5.88 | 8.59 | 37.05 |
| Earnings Per Share (EPS) Growth | -93.08 | -92.85 | -39.34 | 16.89 | 57.42 |
| Asset Growth Rate | 88.69 | 37.59 | 24.51 | 48.85 | 5.56 |
| Net Income Growth Rate | 56.16 | -7.02 | -16.98 | 17.05 | 57.28 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Saroja Pharma Industries India Ltd | 7.47 | 13.67 | Neutral | N/A | N/A | N/A |
| 2 | Sanginita Chemicals Ltd | 7.17 | 62.58 | Undervalued | -6.00 | -3.74 | -10.00 |
| 3 | Yasons Chemex Care Ltd | 5.91 | 21.43 | Neutral | -0.59 | 0.49 | 0.94 |
| 4 | Vadivarhe Speciality Chemicals Ltd | 4.07 | -3.66 | Highly Undervalued | -6.42 | -7.25 | -9.27 |
| 5 | Omkar Speciality Chemicals Ltd | 3.63 | 0.23 | Highly Undervalued | 101.00 | -128.49 | 37.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT